Observational, Prospective, Parallel Cohort Study to Evaluate Tolerability of Canagliflozin and Sulphonylurea on a Background Therapy of Metformin With or Without a DPP-4 Inhibitor During Ramadan Fasting in Patients With Type 2 Diabetes
Phase of Trial: Phase IV
Latest Information Update: 15 Sep 2017
At a glance
- Drugs Canagliflozin (Primary) ; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms CRATOS
- Sponsors Janssen-Cilag
- 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
- 29 Aug 2017 Results published in the International Journal of Clinical Practice.
- 14 Nov 2016 Status changed from active, no longer recruiting to completed.